亨廷顿舞蹈症临床试验角：2019年6月
Huntington's Disease Clinical Trials Corner: June 2019.
作者信息
Rodrigues Filipe B, Ferreira Joaquim J, Wild Edward J
机构信息
UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
出版信息
J Huntingtons Dis. 2019;8(3):363-371. doi: 10.3233/JHD-199003.
Abstract
In this edition of the Huntington's Disease Clinical Trials Corner we expand on the HD-DBS and on the TRIHEP3 trials, and we list all currently registered and ongoing clinical trials in Huntington's disease.
摘要
在本期《亨廷顿舞蹈症临床试验角》中，我们详细介绍了亨廷顿舞蹈症的脑深部电刺激术（HD-DBS）及TRIHEP3试验，并列出了目前所有已注册及正在进行的亨廷顿舞蹈症临床试验。
相似文献
1
Huntington's Disease Clinical Trials Corner: June 2019.
J Huntingtons Dis. 2019;8(3):363-371. doi: 10.3233/JHD-199003.
2
Huntington's Disease Clinical Trials Corner: January 2019.
J Huntingtons Dis. 2019;8(1):115-125. doi: 10.3233/JHD-190001.
3
Huntington's Disease Clinical Trials Corner: April 2020.
J Huntingtons Dis. 2020;9(2):185-197. doi: 10.3233/JHD-200002.
4
Huntington's Disease Clinical Trials Corner: November 2022.
J Huntingtons Dis. 2022;11(4):351-367. doi: 10.3233/JHD-229006.
5
Huntington's Disease Clinical Trials Corner: March 2024.
J Huntingtons Dis. 2024;13(1):1-14. doi: 10.3233/JHD-240017.
6
Huntington's Disease Clinical Trials Corner: August 2018.
J Huntingtons Dis. 2018;7(3):279-286. doi: 10.3233/JHD-189003.
7
Clinical Trials Corner: September 2017.
J Huntingtons Dis. 2017;6(3):255-263. doi: 10.3233/JHD-170262.
8
Huntington's Disease Clinical Trials Corner: April 2022.
J Huntingtons Dis. 2022;11(2):105-118. doi: 10.3233/JHD-229002.
9
Huntington's Disease Clinical Trials Corner: August 2023.
J Huntingtons Dis. 2023;12(2):169-185. doi: 10.3233/JHD-239001.
10
Huntington’s Disease Clinical Trials Corner: February 2018.
J Huntingtons Dis. 2018;7(1):89-98. doi: 10.3233/JHD-189001.
引用本文的文献
1
Huntington's disease clinical trials update: March 2025.
J Huntingtons Dis. 2025 May;14(2):191-206. doi: 10.1177/18796397251337000. Epub 2025 Apr 30.
2
Huntington's Disease Clinical Trials Corner: March 2024.
J Huntingtons Dis. 2024;13(1):1-14. doi: 10.3233/JHD-240017.
3
A cyclic pyrrole-imidazole polyamide reduces pathogenic RNA in CAG/CTG triplet repeat neurological disease models.
J Clin Invest. 2023 Nov 15;133(22):e164792. doi: 10.1172/JCI164792.
4
Huntington's Disease Clinical Trials Corner: August 2023.
J Huntingtons Dis. 2023;12(2):169-185. doi: 10.3233/JHD-239001.
5
Therapeutic Strategies in Huntington's Disease: From Genetic Defect to Gene Therapy.
Biomedicines. 2022 Aug 5;10(8):1895. doi: 10.3390/biomedicines10081895.
6
Current and Possible Future Therapeutic Options for Huntington's Disease.
J Cent Nerv Syst Dis. 2022 May 21;14:11795735221092517. doi: 10.1177/11795735221092517. eCollection 2022.
7
Safety and Feasibility of Research Lumbar Puncture in Huntington's Disease: The HDClarity Cohort and Bioresource.
J Huntingtons Dis. 2022;11(1):59-69. doi: 10.3233/JHD-210508.
8
Metabolism in Huntington's disease: a major contributor to pathology.
Metab Brain Dis. 2022 Aug;37(6):1757-1771. doi: 10.1007/s11011-021-00844-y. Epub 2021 Oct 27.
9
Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination.
Pharmacol Ther. 2022 Feb;230:107967. doi: 10.1016/j.pharmthera.2021.107967. Epub 2021 Aug 14.
10
Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System.
Mol Pharm. 2021 Apr 5;18(4):1491-1506. doi: 10.1021/acs.molpharmaceut.0c01238. Epub 2021 Mar 18.
本文引用的文献
1
Targeting Huntingtin Expression in Patients with Huntington's Disease.
N Engl J Med. 2019 Jun 13;380(24):2307-2316. doi: 10.1056/NEJMoa1900907. Epub 2019 May 6.
2
Huntington's Disease Clinical Trials Corner: January 2019.
J Huntingtons Dis. 2019;8(1):115-125. doi: 10.3233/JHD-190001.
3
Huntington's Disease Clinical Trials Corner: August 2018.
J Huntingtons Dis. 2018;7(3):279-286. doi: 10.3233/JHD-189003.
4
Huntington’s Disease Clinical Trials Corner: February 2018.
J Huntingtons Dis. 2018;7(1):89-98. doi: 10.3233/JHD-189001.
5
Clinical Trials Corner: September 2017.
J Huntingtons Dis. 2017;6(3):255-263. doi: 10.3233/JHD-170262.
6
The CREST-E study of creatine for Huntington disease: A randomized controlled trial.
Neurology. 2017 Aug 8;89(6):594-601. doi: 10.1212/WNL.0000000000004209. Epub 2017 Jul 12.
7
Triheptanoin for the treatment of brain energy deficit: A 14-year experience.
J Neurosci Res. 2017 Nov;95(11):2236-2243. doi: 10.1002/jnr.24111. Epub 2017 Jul 8.
8
Fifteen Years of Clinical Trials in Huntington's Disease: A Very Low Clinical Drug Development Success Rate.
J Huntingtons Dis. 2017;6(2):157-163. doi: 10.3233/JHD-170245.
9
Deep Brain Stimulation in Huntington's Disease-Preliminary Evidence on Pathophysiology, Efficacy and Safety.
Brain Sci. 2016 Aug 30;6(3):38. doi: 10.3390/brainsci6030038.
10
Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency.
J Neurol Neurosurg Psychiatry. 2016 May;87(5):550-3. doi: 10.1136/jnnp-2015-311475. Epub 2015 Nov 3.
Zotero 插件